Registro:

Referencias:

• Hanahan, D., Coussens, L.M., Accessories to the crime: functions of cells recruited to the tumor microenvironment (2012) Cancer Cell, 21 (3), pp. 309-322
• Marx, J., Cancer biology. All in the stroma: cancer's Cosa Nostra (2008) Science, 320 (5872), pp. 38-41
• Junttila, M.R., de Sauvage, F.J., Influence of tumour micro-environment heterogeneity on therapeutic response (2013) Nature, 501 (7467), pp. 346-354
• Barondes, S.H., Castronovo, V., Cooper, D.N., Galectins: a family of animal beta-galactoside-binding lectins (1994) Cell, 76 (4), pp. 597-598
• Yang, R.Y., Rabinovich, G.A., Liu, F.T., Galectins: structure, function and therapeutic potential (2008) Expert. Rev. Mol. Med., 10, p. e17
• Rabinovich, G.A., Croci, D.O., Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer (2012) Immunity, 36 (3), pp. 322-335
• Sundblad, V., Morosi, L.G., Geffner, J.R., Galectin-1: a jack-of-all-trades in the resolution of acute and chronic inflammation (2017) J. Immunol., 199 (11), pp. 3721-3730
• Liu, F.T., Rabinovich, G.A., Galectins as modulators of tumour progression (2005) Nat. Rev. Cancer, 5 (1), pp. 29-41
• Cerliani, J.P., Blidner, A.G., Toscano, M.A., Translating the ‘sugar code’ into immune and vascular signaling programs (2017) Trends Biochem. Sci., 42 (4), pp. 255-273
• Jung, E.J., Moon, H.G., Cho, B.I., Galectin-1 expression in cancer-associated stromal cells correlates tumor invasiveness and tumor progression in breast cancer (2007) Int. J. Cancer, 120 (11), pp. 2331-2338
• Grosset, A.A., Labrie, M., Vladoiu, M.C., Galectin signatures contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets (2016) Oncotarget, 7 (14), pp. 18183-18203
• Lacina, L., Plzak, J., Kodet, O., Cancer microenvironment: What can we learn from the stem cell niche (2015) Int. J. Mol. Sci., 16 (10), pp. 24094-24110
• Attieh, Y., Vignjevic, D.M., The hallmarks of CAFs in cancer invasion (2016) Eur. J. Cell Biol., 95 (11), pp. 493-502
• Kuzet, S.E., Gaggioli, C., Fibroblast activation in cancer: when seed fertilizes soil (2016) Cell Tissue Res., 365 (3), pp. 607-619
• Marsh, T., Pietras, K., McAllister, S.S., Fibroblasts as architects of cancer pathogenesis (2013) Biochim. Biophys. Acta, 1832 (7), pp. 1070-1078
• Kalluri, R., The biology and function of fibroblasts in cancer (2016) Nat. Rev. Cancer, 16 (9), pp. 582-598
• Xing, F., Saidou, J., Watabe, K., Cancer associated fibroblasts (CAFs) in tumor microenvironment (2010) Front. Biosci., 15, pp. 166-179
• Quante, M., Tu, S.P., Tomita, H., Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth (2011) Cancer Cell, 19 (2), pp. 257-272
• Sounni, N.E., Noel, A., Targeting the tumor microenvironment for cancer therapy (2013) Clin. Chem., 59 (1), pp. 85-93
• Luga, V., Zhang, L., Viloria-Petit, A.M., Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration (2012) Cell, 151 (7), pp. 1542-1556
• Comito, G., Giannoni, E., Di Gennaro, P., Stromal fibroblasts synergize with hypoxic oxidative stress to enhance melanoma aggressiveness (2012) Cancer Lett., 324 (1), pp. 31-41
• Yamauchi, M., Barker, T.H., Gibbons, D.L., The fibrotic tumor stroma (2017) J. Clin. Invest., 128 (1), pp. 16-25
• Abbott, W.M., Mellor, A., Edwards, Y., Soluble bovine galactose-binding lectin. cDNA cloning reveals the complete amino acid sequence and an antigenic relationship with the major encephalitogenic domain of myelin basic protein (1989) Biochem. J., 259 (1), pp. 283-290
• Xu, X.C., El-Naggar, A.K., Lotan, R., Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications (1995) Am. J. Pathol., 147 (3), pp. 815-822
• Gillenwater, A., Xu, X.C., el-Naggar, A.K., Expression of galectins in head and neck squamous cell carcinoma (1996) Head Neck, 18 (5), pp. 422-432
• Sanjuan, X., Fernandez, P.L., Castells, A., Differential expression of galectin 3 and galectin 1 in colorectal cancer progression (1997) Gastroenterology, 113 (6), pp. 1906-1915
• van den Brule, F.A., Waltregny, D., Castronovo, V., Increased expression of galectin-1 in carcinoma-associated stroma predicts poor outcome in prostate carcinoma patients (2001) J. Pathol., 193 (1), pp. 80-87
• van den Brule, F., Califice, S., Garnier, F., Galectin-1 accumulation in the ovary carcinoma peritumoral stroma is induced by ovary carcinoma cells and affects both cancer cell proliferation and adhesion to laminin-1 and fibronectin (2003) Lab. Invest., 83 (3), pp. 377-386
• Kim, H.J., Jeon, H.K., Cho, Y.J., High galectin-1 expression correlates with poor prognosis and is involved in epithelial ovarian cancer proliferation and invasion (2012) Eur. J. Cancer, 48 (12), pp. 1914-1921
• Valach, J., Fik, Z., Strnad, H., Smooth muscle actin-expressing stromal fibroblasts in head and neck squamous cell carcinoma: increased expression of galectin-1 and induction of poor prognosis factors (2012) Int. J. Cancer, 131 (11), pp. 2499-2508
• Wu, M.H., Hong, H.C., Hong, T.M., Targeting galectin-1 in carcinoma-associated fibroblasts inhibits oral squamous cell carcinoma metastasis by downregulating MCP-1/CCL2 expression (2011) Clin. Cancer Res., 17 (6), pp. 1306-1316
• Kolar, M., Szabo, P., Dvorankova, B., Upregulation of IL-6, IL-8 and CXCL-1 production in dermal fibroblasts by normal/malignant epithelial cells in vitro: Immunohistochemical and transcriptomic analyses (2012) Biol. Cell, 104 (12), pp. 738-751
• He, X.J., Tao, H.Q., Hu, Z.M., Expression of galectin-1 in carcinoma-associated fibroblasts promotes gastric cancer cell invasion through upregulation of integrin beta1 (2014) Cancer Sci., 105 (11), pp. 1402-1410
• Zheng, L., Xu, C., Guan, Z., Galectin-1 mediates TGF-beta-induced transformation from normal fibroblasts into carcinoma-associated fibroblasts and promotes tumor progression in gastric cancer (2016) Am. J. Transl. Res., 8 (4), pp. 1641-1658
• Berberat, P.O., Friess, H., Wang, L., Comparative analysis of galectins in primary tumors and tumor metastasis in human pancreatic cancer (2001) J. Histochem. Cytochem., 49 (4), pp. 539-549
• Masamune, A., Satoh, M., Hirabayashi, J., Galectin-1 induces chemokine production and proliferation in pancreatic stellate cells (2006) Am. J. Physiol. Gastrointest. Liver Physiol., 290 (4), pp. G729-736
• Fitzner, B., Walzel, H., Sparmann, G., Galectin-1 is an inductor of pancreatic stellate cell activation (2005) Cell. Signal., 17 (10), pp. 1240-1247
• Xue, X., Lu, Z., Tang, D., Galectin-1 secreted by activated stellate cells in pancreatic ductal adenocarcinoma stroma promotes proliferation and invasion of pancreatic cancer cells: an in vitro study on the microenvironment of pancreatic ductal adenocarcinoma (2011) Pancreas, 40 (6), pp. 832-839
• Tang, D., Zhang, J., Yuan, Z., Pancreatic satellite cells derived galectin-1 increase the progression and less survival of pancreatic ductal adenocarcinoma (2014) PLoS One, 9 (3), p. e90476
• Martinez-Bosch, N., Fernandez-Barrena, M.G., Moreno, M., Galectin-1 drives pancreatic carcinogenesis through stroma remodeling and Hedgehog signaling activation (2014) Cancer Res., 74 (13), pp. 3512-3524
• Kristensen, D.B., Kawada, N., Imamura, K., Proteome analysis of rat hepatic stellate cells (2000) Hepatology, 32 (2), pp. 268-277
• Maeda, N., Kawada, N., Seki, S., Stimulation of proliferation of rat hepatic stellate cells by galectin-1 and galectin-3 through different intracellular signaling pathways (2003) J. Biol. Chem., 278 (21), pp. 18938-18944
• Folgueira, M.A., Maistro, S., Katayama, M.L., Markers of breast cancer stromal fibroblasts in the primary tumour site associated with lymph node metastasis: a systematic review including our case series (2013) Biosci. Rep., 33 (6), pp. 921-929
• Zhu, X., Wang, K., Zhang, K., Galectin-1 knockdown in carcinoma-associated fibroblasts inhibits migration and invasion of human MDA-MB-231 breast cancer cells by modulating MMP-9 expression (2016) Acta Biochim. Biophys. Sin. (Shanghai), 48 (5), pp. 462-467
• Lim, M.J., Ahn, J., Yi, J.Y., Induction of galectin-1 by TGF-beta1 accelerates fibrosis through enhancing nuclear retention of Smad2 (2014) Exp. Cell Res., 326 (1), pp. 125-135
• Moutsatsos, I.K., Wade, M., Schindler, M., Endogenous lectins from cultured cells: nuclear localization of carbohydrate-binding protein 35 in proliferating 3T3 fibroblasts (1987) Proc. Natl. Acad. Sci. U.S.A., 84 (18), pp. 6452-6456
• Hamann, K.K., Cowles, E.A., Wang, J.L., Expression of carbohydrate binding protein 35 in human fibroblasts: variations in the levels of mRNA, protein, and isoelectric species as a function of replicative competence (1991) Exp. Cell Res., 196 (1), pp. 82-91
• Tsay, Y.G., Lin, N.Y., Voss, P.G., Export of galectin-3 from nuclei of digitonin-permeabilized mouse 3T3 fibroblasts (1999) Exp. Cell Res., 252 (2), pp. 250-261
• Openo, K.P., Kadrofske, M.M., Patterson, R.J., Galectin-3 expression and subcellular localization in senescent human fibroblasts (2000) Exp. Cell Res., 255 (2), pp. 278-290
• Alkasalias, T., Flaberg, E., Kashuba, V., Inhibition of tumor cell proliferation and motility by fibroblasts is both contact and soluble factor dependent (2014) Proc. Natl. Acad. Sci. U.S.A., 111 (48), pp. 17188-17193
• Tadokoro, T., Ikekita, M., Toda, T., Involvement of Galectin-3 with vascular cell adhesion molecule-1 in growth regulation of mouse BALB/3T3 cells (2009) J. Biol. Chem., 284 (51), pp. 35556-35563
• Kim, S.J., Lee, H.W., Gu Kang, H., Ablation of galectin-3 induces p27(KIP1)-dependent premature senescence without oncogenic stress (2014) Cell Death Differ., 21 (11), pp. 1769-1779
• Henderson, N.C., Mackinnon, A.C., Farnworth, S.L., Galectin-3 regulates myofibroblast activation and hepatic fibrosis (2006) Proc. Natl. Acad. Sci. U.S.A., 103 (13), pp. 5060-5065
• Henderson, N.C., Sethi, T., The regulation of inflammation by galectin-3 (2009) Immunol. Rev., 230 (1), pp. 160-171
• Mackinnon, A.C., Gibbons, M.A., Farnworth, S.L., Regulation of transforming growth factor-beta1-driven lung fibrosis by galectin-3 (2012) Am. J. Respir. Crit. Care Med., 185 (5), pp. 537-546
• Lippert, E., Falk, W., Bataille, F., Soluble galectin-3 is a strong, colonic epithelial-cell-derived, lamina propria fibroblast-stimulating factor (2007) Gut, 56 (1), pp. 43-51
• Lippert, E., Gunckel, M., Brenmoehl, J., Regulation of galectin-3 function in mucosal fibroblasts: potential role in mucosal inflammation (2008) Clin. Exp. Immunol., 152 (2), pp. 285-297
• Filer, A., Bik, M., Parsonage, G.N., Galectin 3 induces a distinctive pattern of cytokine and chemokine production in rheumatoid synovial fibroblasts via selective signaling pathways (2009) Arthritis Rheum., 60 (6), pp. 1604-1614
• Sharma, U.C., Pokharel, S., van Brakel, T.J., Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction (2004) Circulation, 110 (19), pp. 3121-3128
• Chen, W.S., Cao, Z., Leffler, H., Galectin-3 inhibition by a small-molecule inhibitor reduces both pathological corneal neovascularization and fibrosis (2017) Invest. Ophthalmol. Vis. Sci., 58 (1), pp. 9-20
• Raz, A., Zhu, D.G., Hogan, V., Evidence for the role of 34-kDa galactoside-binding lectin in transformation and metastasis (1990) Int. J. Cancer, 46 (5), pp. 871-877
• Dvorankova, B., Szabo, P., Lacina, L., Human galectins induce conversion of dermal fibroblasts into myofibroblasts and production of extracellular matrix: potential application in tissue engineering and wound repair (2011) Cells Tissues Organs, 194 (6), pp. 469-480
• Nangia-Makker, P., Balan, V., Raz, A., Regulation of tumor progression by extracellular galectin-3 (2008) Cancer Microenviron., 1 (1), pp. 43-51
• Fortuna-Costa, A., Gomes, A.M., Kozlowski, E.O., Extracellular galectin-3 in tumor progression and metastasis (2014) Front. Oncol., 4, p. 138
• Logullo, A.F., Lopes, A.B., Nonogaki, S., C-erbB-2 expression is a better predictor for survival than galectin-3 or p53 in early-stage breast cancer (2007) Oncol. Rep., 18 (1), pp. 121-126
• Moisa, A., Fritz, P., Eck, A., Growth/adhesion-regulatory tissue lectin galectin-3: stromal presence but not cytoplasmic/nuclear expression in tumor cells as a negative prognostic factor in breast cancer (2007) Anticancer Res., 27 (4B), pp. 2131-2139
• Vanderstraeten, A., Luyten, C., Verbist, G., Mapping the immunosuppressive environment in uterine tumors: implications for immunotherapy (2014) Cancer Immunol. Immunother., 63 (6), pp. 545-557
• Takano, T., Miyauchi, A., Matsuzuka, F., Ubiquitous expression of galectin-3 mRNA in benign and malignant thyroid tumors (2003) Cancer Lett., 199 (1), pp. 69-73
• Estofolete, C.F., Zucoloto, S., Oliani, S.M., Myenteric denervation downregulates galectin-1 and -3 expression in gastric carcinogenesis (2011) Dig. Dis. Sci., 56 (6), pp. 1637-1644
• La, S.H., Kim, S.J., Kang, H.G., Ablation of human telomerase reverse transcriptase (hTERT) induces cellular senescence in gastric cancer through a galectin-3 dependent mechanism (2016) Oncotarget, 7 (35), pp. 57117-57130
• Greijer, A.E., van der Groep, P., Kemming, D., Up-regulation of gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor 1 (HIF-1) (2005) J. Pathol., 206 (3), pp. 291-304
• Zeng, Y., Danielson, K.G., Albert, T.J., HIF-1 alpha is a regulator of galectin-3 expression in the intervertebral disc (2007) J. Bone. Miner. Res., 22 (12), pp. 1851-1861
• Levy, R., Biran, A., Poirier, F., Galectin-3 mediates cross-talk between K-Ras and Let-7c tumor suppressor microRNA (2011) PLoS One, 6 (11), p. e27490
• Thijssen, V.L., Rabinovich, G.A., Griffioen, A.W., Vascular galectins: regulators of tumor progression and targets for cancer therapy (2013) Cytokine Growth Factor Rev., 24 (6), pp. 547-558
• Baum, L.G., Seilhamer, J.J., Pang, M., Synthesis of an endogeneous lectin, galectin-1, by human endothelial cells is up-regulated by endothelial cell activation (1995) Glycoconj. J., 12 (1), pp. 63-68
• Thijssen, V.L., Hulsmans, S., Griffioen, A.W., The galectin profile of the endothelium: altered expression and localization in activated and tumor endothelial cells (2008) Am. J. Pathol., 172 (2), pp. 545-553
• Thijssen, V.L., Postel, R., Brandwijk, R.J., Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy (2006) Proc. Natl. Acad. Sci. U.S.A., 103 (43), pp. 15975-15980
• Clausse, N., van den Brule, F., Waltregny, D., Galectin-1 expression in prostate tumor-associated capillary endothelial cells is increased by prostate carcinoma cells and modulates heterotypic cell-cell adhesion (1999) Angiogenesis, 3 (4), pp. 317-325
• Hsieh, S.H., Ying, N.W., Wu, M.H., Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells (2008) Oncogene, 27 (26), pp. 3746-3753
• Croci, D.O., Salatino, M., Rubinstein, N., Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma (2012) J. Exp. Med., 209 (11), pp. 1985-2000
• Croci, D.O., Cerliani, J.P., Dalotto-Moreno, T., Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors (2014) Cell, 156 (4), pp. 744-758
• Thijssen, V.L., Barkan, B., Shoji, H., Tumor cells secrete galectin-1 to enhance endothelial cell activity (2010) Cancer Res., 70 (15), pp. 6216-6224
• Zhao, X.Y., Zhao, K.W., Jiang, Y., Synergistic induction of galectin-1 by CCAAT/enhancer binding protein alpha and hypoxia-inducible factor 1alpha and its role in differentiation of acute myeloid leukemic cells (2011) J. Biol. Chem., 286 (42), pp. 36808-36819
• White, N.M., Masui, O., Newsted, D., Galectin-1 has potential prognostic significance and is implicated in clear cell renal cell carcinoma progression through the HIF/mTOR signaling axis (2014) Br. J. Cancer, 110 (5), pp. 1250-1259
• Laderach, D.J., Gentilini, L.D., Giribaldi, L., A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease (2013) Cancer Res., 73 (1), pp. 86-96
• D'Haene, N., Sauvage, S., Maris, C., VEGFR1 and VEGFR2 involvement in extracellular galectin-1- and galectin-3-induced angiogenesis (2013) PLoS One, 8 (6), p. e67029
• Williams, S.P., Odell, A.F., Karnezis, T., Genome-wide functional analysis reveals central signaling regulators of lymphatic endothelial cell migration and remodeling (2017) Sci. Signal., 10 (499)
• Nangia-Makker, P., Honjo, Y., Sarvis, R., Galectin-3 induces endothelial cell morphogenesis and angiogenesis (2000) Am. J. Pathol., 156 (3), pp. 899-909
• Yang, E., Shim, J.S., Woo, H.J., Aminopeptidase N/CD13 induces angiogenesis through interaction with a pro-angiogenic protein, galectin-3 (2007) Biochem. Biophys. Res. Commun., 363 (2), pp. 336-341
• Markowska, A.I., Liu, F.T., Panjwani, N., Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response (2010) J. Exp. Med., 207 (9), pp. 1981-1993
• Markowska, A.I., Jefferies, K.C., Panjwani, N., Galectin-3 protein modulates cell surface expression and activation of vascular endothelial growth factor receptor 2 in human endothelial cells (2011) J. Biol. Chem., 286 (34), pp. 29913-29921
• Delgado, V.M., Nugnes, L.G., Colombo, L.L., Modulation of endothelial cell migration and angiogenesis: a novel function for the “tandem-repeat” lectin galectin-8 (2011) FASEB J., 25 (1), pp. 242-254
• Cueni, L.N., Detmar, M., Galectin-8 interacts with podoplanin and modulates lymphatic endothelial cell functions (2009) Exp. Cell Res., 315 (10), pp. 1715-1723
• Chen, W.S., Cao, Z., Sugaya, S., Pathological lymphangiogenesis is modulated by galectin-8-dependent crosstalk between podoplanin and integrin-associated VEGFR-3 (2016) Nat. Commun., 7, p. 11302
• Mendez-Huergo, S.P., Blidner, A.G., Rabinovich, G.A., Galectins: emerging regulatory checkpoints linking tumor immunity and angiogenesis (2017) Curr. Opin. Immunol., 45, pp. 8-15
• Rabinovich, G.A., Conejo-Garcia, J.R., Shaping the immune landscape in cancer by galectin-driven regulatory pathways (2016) J. Mol. Biol., 428 (16), pp. 3266-3281
• Rubinstein, N., Alvarez, M., Zwirner, N.W., Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection. A potential mechanism of tumor-immune privilege (2004) Cancer Cell, 5 (3), pp. 241-251
• Le, Q.T., Shi, G., Cao, H., Galectin-1: a link between tumor hypoxia and tumor immune privilege (2005) J. Clin. Oncol., 23 (35), pp. 8932-8941
• Soldati, R., Berger, E., Zenclussen, A.C., Neuroblastoma triggers an immunoevasive program involving galectin-1-dependent modulation of T cell and dendritic cell compartments (2012) Int. J. Cancer, 131 (5), pp. 1131-1141
• Banh, A., Zhang, J., Cao, H., Tumor galectin-1 mediates tumor growth and metastasis through regulation of T-cell apoptosis (2011) Cancer Res., 71 (13), pp. 4423-4431
• Tang, D., Yuan, Z., Xue, X., High expression of Galectin-1 in pancreatic stellate cells plays a role in the development and maintenance of an immunosuppressive microenvironment in pancreatic cancer (2012) Int. J. Cancer, 130 (10), pp. 2337-2348
• Toscano, M.A., Bianco, G.A., Ilarregui, J.M., Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death (2007) Nat. Immunol., 8 (8), pp. 825-834
• Blidner, A.G., Mendez-Huergo, S.P., Cagnoni, A.J., Re-wiring regulatory cell networks in immunity by galectin-glycan interactions (2015) FEBS Lett., 589 (22), pp. 3407-3418
• Sugimoto, N., Oida, T., Hirota, K., Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis (2006) Int. Immunol., 18 (8), pp. 1197-1209
• Garin, M.I., Chu, C.C., Golshayan, D., Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells (2007) Blood, 109 (5), pp. 2058-2065
• Dalotto-Moreno, T., Croci, D.O., Cerliani, J.P., Targeting galectin-1 overcomes breast cancer-associated immunosuppression and prevents metastatic disease (2012) Cancer Res., 73 (3), pp. 1107-1117
• Juszczynski, P., Ouyang, J., Monti, S., The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma (2007) Proc. Natl. Acad. Sci. U.S.A., 104 (32), pp. 13134-13139
• Rodig, S.J., Ouyang, J., Juszczynski, P., AP1-dependent galectin-1 expression delineates classical hodgkin and anaplastic large cell lymphomas from other lymphoid malignancies with shared molecular features (2008) Clin. Cancer Res., 14 (11), pp. 3338-3344
• Cedeno-Laurent, F., Opperman, M., Barthel, S.R., Galectin-1 triggers an immunoregulatory signature in Th cells functionally defined by IL-10 expression (2012) J. Immunol., 188 (7), pp. 3127-3137
• Ilarregui, J.M., Croci, D.O., Bianco, G.A., Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10 (2009) Nat. Immunol., 10 (9), pp. 981-991
• Kuo, P.L., Hung, J.Y., Huang, S.K., Lung cancer-derived galectin-1 mediates dendritic cell anergy through inhibitor of DNA binding 3/IL-10 signaling pathway (2011) J. Immunol., 186 (3), pp. 1521-1530
• Tesone, A.J., Rutkowski, M.R., Brencicova, E., Satb1 overexpression drives tumor-promoting activities in cancer-associated dendritic cells (2016) Cell Rep., 14 (7), pp. 1774-1786
• Hsu, Y.L., Hung, J.Y., Chiang, S.Y., Lung cancer-derived galectin-1 contributes to cancer associated fibroblast-mediated cancer progression and immune suppression through TDO2/kynurenine axis (2016) Oncotarget, 7 (19), pp. 27584-27598
• Ouyang, J., Juszczynski, P., Rodig, S.J., Viral induction and targeted inhibition of galectin-1 in EBV+ posttransplant lymphoproliferative disorders (2011) Blood, 117 (16), pp. 4315-4322
• Baker, G.J., Chockley, P., Yadav, V.N., Natural killer cells eradicate galectin-1-deficient glioma in the absence of adaptive immunity (2014) Cancer Res., 74 (18), pp. 5079-5090
• Baker, G.J., Chockley, P., Zamler, D., Natural killer cells require monocytic Gr-1(+)/CD11b(+) myeloid cells to eradicate orthotopically engrafted glioma cells (2016) Oncoimmunology, 5 (6), p. e1163461
• Correa, S.G., Sotomayor, C.E., Aoki, M.P., Opposite effects of galectin-1 on alternative metabolic pathways of L-arginine in resident, inflammatory, and activated macrophages (2003) Glycobiology, 13 (2), pp. 119-128
• Barrionuevo, P., Beigier-Bompadre, M., Ilarregui, J.M., A novel function for galectin-1 at the crossroad of innate and adaptive immunity: galectin-1 regulates monocyte/macrophage physiology through a nonapoptotic ERK-dependent pathway (2007) J. Immunol., 178 (1), pp. 436-445
• Rostoker, R., Yaseen, H., Schif-Zuck, S., Galectin-1 induces 12/15-lipoxygenase expression in murine macrophages and favors their conversion toward a pro-resolving phenotype (2013) Prostaglandins Other Lipid Mediat., 107, pp. 85-94
• Verschuere, T., Toelen, J., Maes, W., Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity (2014) Int. J. Cancer, 134 (4), pp. 873-884
• Starossom, S.C., Mascanfroni, I.D., Imitola, J., Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration (2012) Immunity, 37 (2), pp. 249-263
• Van Woensel, M., Mathivet, T., Wauthoz, N., Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy (2017) Sci. Rep., 7 (1), p. 1217
• Andersen, M.N., Ludvigsen, M., Abildgaard, N., Serum galectin-1 in patients with multiple myeloma: associations with survival, angiogenesis, and biomarkers of macrophage activation (2017) Onco. Targets Ther., 10, pp. 1977-1982
• Schupp, J., Krebs, F.K., Zimmer, N., Targeting myeloid cells in the tumor sustaining microenvironment (2017) Cell Immunol.
• Blidner, A.G., Salatino, M., Mascanfroni, I.D., Differential response of myeloid-derived suppressor cells to the nonsteroidal anti-inflammatory agent indomethacin in tumor-associated and tumor-free microenvironments (2015) J. Immunol., 194 (7), pp. 3452-3462
• Rutkowski, M.R., Stephen, T.L., Svoronos, N., Microbially driven TLR5-dependent signaling governs distal malignant progression through tumor-promoting inflammation (2015) Cancer Cell, 27 (1), pp. 27-40
• Croci, D.O., Morande, P.E., Dergan-Dylon, S., Nurse-like cells control the activity of chronic lymphocytic leukemia B cells via galectin-1 (2013) Leukemia, 27 (6), pp. 1413-1416
• Fukumori, T., Takenaka, Y., Yoshii, T., CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis (2003) Cancer Res., 63 (23), pp. 8302-8311
• Hsu, D.K., Chen, H.Y., Liu, F.T., Galectin-3 regulates T-cell functions (2009) Immunol. Rev., 230 (1), pp. 114-127
• Peng, W., Wang, H.Y., Miyahara, Y., Tumor-associated galectin-3 modulates the function of tumor-reactive T cells (2008) Cancer Res., 68 (17), pp. 7228-7236
• Guha, P., Kaptan, E., Bandyopadhyaya, G., Cod glycopeptide with picomolar affinity to galectin-3 suppresses T-cell apoptosis and prostate cancer metastasis (2013) Proc. Natl. Acad. Sci. U.S.A., 110 (13), pp. 5052-5057
• Demotte, N., Stroobant, V., Courtoy, P.J., Restoring the association of the T cell receptor with CD8 reverses anergy in human tumor-infiltrating lymphocytes (2008) Immunity, 28 (3), pp. 414-424
• Demotte, N., Wieers, G., Van Der Smissen, P., A galectin-3 ligand corrects the impaired function of human CD4 and CD8 tumor-infiltrating lymphocytes and favors tumor rejection in mice (2010) Cancer Res., 70 (19), pp. 7476-7488
• Gordon-Alonso, M., Hirsch, T., Wildmann, C., Galectin-3 captures interferon-gamma in the tumor matrix reducing chemokine gradient production and T-cell tumor infiltration (2017) Nat. Commun., 8 (1), p. 793
• Kouo, T., Huang, L., Pucsek, A.B., Galectin-3 shapes antitumor immune responses by suppressing CD8+ T cells via LAG-3 and inhibiting expansion of plasmacytoid dendritic cells (2015) Cancer Immunol. Res., 3 (4), pp. 412-423
• Sakuishi, K., Jayaraman, P., Behar, S.M., Emerging Tim-3 functions in antimicrobial and tumor immunity (2011) Trends Immunol., 32 (8), pp. 345-349
• Weber, M., Buttner-Herold, M., Distel, L., Galectin 3 expression in primary oral squamous cell carcinomas (2017) BMC Cancer, 17 (1), p. 906
• Radosavljevic, G., Jovanovic, I., Majstorovic, I., Deletion of galectin-3 in the host attenuates metastasis of murine melanoma by modulating tumor adhesion and NK cell activity (2011) Clin. Exp. Metastasis, 28 (5), pp. 451-462
• Tsuboi, S., Sutoh, M., Hatakeyama, S., A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycans (2011) Embo. J., 30 (15), pp. 3173-3185
• Wang, W., Guo, H., Geng, J., Tumor-released Galectin-3, a soluble inhibitory ligand of human NKp30, plays an important role in tumor escape from NK cell attack (2014) J. Biol. Chem., 289 (48), pp. 33311-33319
• Molinero, L.L., Fuertes, M.B., Rabinovich, G.A., Activation-induced expression of MICA on T lymphocytes involves engagement of CD3 and CD28 (2002) J. Leukoc. Biol., 71 (5), pp. 791-797
• Sampson, J.F., Suryawanshi, A., Chen, W.S., Galectin-8 promotes regulatory T-cell differentiation by modulating IL-2 and TGFbeta signaling (2016) Immunol. Cell Biol., 94 (2), p. 220
• Levy, Y., Ronen, D., Bershadsky, A.D., Sustained induction of ERK, protein kinase B, and p70 S6 kinase regulates cell spreading and formation of F-actin microspikes upon ligation of integrins by galectin-8, a mammalian lectin (2003) J. Biol. Chem., 278 (16), pp. 14533-14542
• Dardalhon, V., Anderson, A.C., Karman, J., Tim-3/galectin-9 pathway: regulation of Th1 immunity through promotion of CD11b+Ly-6G+ myeloid cells (2010) J. Immunol., 185 (3), pp. 1383-1392
• Wu, C., Thalhamer, T., Franca, R.F., Galectin-9-CD44 interaction enhances stability and function of adaptive regulatory T cells (2014) Immunity, 41 (2), pp. 270-282
• Daley, D., Mani, V.R., Mohan, N., Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance (2017) Nat. Med., 23 (5), pp. 556-567
• Klover, P.J., Thangapazham, R.L., Kato, J., Tsc2 disruption in mesenchymal progenitors results in tumors with vascular anomalies overexpressing Lgals3 (2017) Elife, 6, p. e23202
• Rabinovich, G.A., Cumashi, A., Bianco, G.A., Synthetic lactulose amines: novel class of anticancer agents that induce tumor-cell apoptosis and inhibit galectin-mediated homotypic cell aggregation and endothelial cell morphogenesis (2006) Glycobiology, 16 (3), pp. 210-220
• Oberg, C.T., Leffler, H., Nilsson, U.J., Inhibition of galectins with small molecules (2011) Chimia (Aarau), 65 (1-2), pp. 18-23
• van Hattum, H., Branderhorst, H.M., Moret, E.E., Tuning the preference of thiodigalactoside- and lactosamine-based ligands to galectin-3 over galectin-1 (2013) J. Med. Chem., 56 (3), pp. 1350-1354
• Delaine, T., Collins, P., MacKinnon, A., Galectin-3-binding glycomimetics that strongly reduce bleomycin-induced lung fibrosis and modulate intracellular glycan recognition (2016) Chembiochem., 17 (18), pp. 1759-1770
• Zetterberg, F.R., Peterson, K., Johnsson, R.E., Monosaccharide derivatives with low-nanomolar lectin affinity and high selectivity based on combined fluorine-amide, phenyl-arginine, sulfur-pi, and halogen bond interactions (2018) ChemMedChem, 13 (2), pp. 133-137
• Zhang, H., Laaf, D., Elling, L., Thiodigalactoside-bovine serum albumin conjugates as high-potency inhibitors of galectin-3: an outstanding example of multivalent presentation of small molecule inhibitors (2018) Bioconjug. Chem.
• Nangia-Makker, P., Hogan, V., Honjo, Y., Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin (2002) J. Natl. Cancer Inst., 94 (24), pp. 1854-1862
• Glinsky, V.V., Raz, A., Modified citrus pectin anti-metastatic properties: one bullet, multiple targets (2009) Carbohydr. Res., 344 (14), pp. 1788-1791
• Stegmayr, J., Lepur, A., Kahl-Knutson, B., Low or no inhibitory potency of the canonical galectin carbohydrate-binding site by pectins and galactomannans (2016) J. Biol. Chem., 291 (25), pp. 13318-13334
• Griffioen, A.W., van der Schaft, D.W., Barendsz-Janson, A.F., Anginex, a designed peptide that inhibits angiogenesis (2001) Biochem. J., 354, pp. 233-242
• Mayo, K.H., Dings, R.P., Flader, C., Design of a partial peptide mimetic of anginex with antiangiogenic and anticancer activity (2003) J. Biol. Chem., 278 (46), pp. 45746-45752
• Astorgues-Xerri, L., Riveiro, M.E., Tijeras-Raballand, A., OTX008, a selective small-molecule inhibitor of galectin-1, downregulates cancer cell proliferation, invasion and tumour angiogenesis (2014) Eur. J. Cancer, 50 (14), pp. 2463-2477
• Lappchen, T., Dings, R.P., Rossin, R., Novel analogs of antitumor agent calixarene 0118: Synthesis, cytotoxicity, click labeling with 2-[18F]fluoroethylazide, and in vivo evaluation (2015) Eur. J. Med. Chem., 89, pp. 279-295

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------